Limitations of the available SmSWP mixtures prevented us from including a control group treated with SmSWP, but we know from our previous experiments that SmSWP treatment (25 μg) given 6 h after TNBS colitis induction, did not affect the inflammatory parameters studied in control Swiss OF1 mice (clinical disease score, macroscopic and microscopic inflammation scores and MPO activity) [23]. Here, MPO is linked to colitis.